FDA Drug Application (022331) for KAPVAY by CONCORDIA PHARMS INC

Back to FDA Applications sponsored by CONCORDIA PHARMS INC

Application Number022331
Product Number003
FormTABLET, EXTENDED RELEASE;ORAL
Dosage0.1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameKAPVAY
Active IngredientCLONIDINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CLONIDINE HYDROCHLORIDE8


Back to FDA Applications sponsored by CONCORDIA PHARMS INC